Nature Communications (Feb 2024)

Cellular reprogramming in vivo initiated by SOX4 pioneer factor activity

  • Takeshi Katsuda,
  • Jonathan H. Sussman,
  • Kenji Ito,
  • Andrew Katznelson,
  • Salina Yuan,
  • Naomi Takenaka,
  • Jinyang Li,
  • Allyson J. Merrell,
  • Hector Cure,
  • Qinglan Li,
  • Reyaz Ur Rasool,
  • Irfan A. Asangani,
  • Kenneth S. Zaret,
  • Ben Z. Stanger

DOI
https://doi.org/10.1038/s41467-024-45939-z
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 20

Abstract

Read online

Abstract Tissue damage elicits cell fate switching through a process called metaplasia, but how the starting cell fate is silenced and the new cell fate is activated has not been investigated in animals. In cell culture, pioneer transcription factors mediate “reprogramming” by opening new chromatin sites for expression that can attract transcription factors from the starting cell’s enhancers. Here we report that SOX4 is sufficient to initiate hepatobiliary metaplasia in the adult mouse liver, closely mimicking metaplasia initiated by toxic damage to the liver. In lineage-traced cells, we assessed the timing of SOX4-mediated opening of enhancer chromatin versus enhancer decommissioning. Initially, SOX4 directly binds to and closes hepatocyte regulatory sequences via an overlapping motif with HNF4A, a hepatocyte master regulatory transcription factor. Subsequently, SOX4 exerts pioneer factor activity to open biliary regulatory sequences. The results delineate a hierarchy by which gene networks become reprogrammed under physiological conditions, providing deeper insight into the basis for cell fate transitions in animals.